Dennis A. Ausiello is a corporate insider at Seres Therapeutics, Inc. (MCRB). SEC records also connect Ausiello to Rani Therapeutics Holdings, Inc. (RANI) and ALNYLAM PHARMACEUTICALS, INC. (ALNY). Ausiello has reported 8 insider filings with the SEC since 2024. The most recent filing was in July 2026.
Every role Dennis A. Ausiello has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Seres Therapeutics, Inc. (MCRB)2 filingsRani Therapeutics Holdings, Inc. (RANI)1 filingUpdated Aug 30, 2026
Dennis A. Ausiello files SEC Form 4 reports at Seres Therapeutics, Inc. (MCRB). 8 SEC Form 4 filings on record going back to 2024, most recently on 10 July 2026. Most recent open-market trade: sold $284K of ALNY on 14 August 2025. Lifetime open-market sales: $13.73M.
Every recent SEC Form 4 transaction Dennis A. Ausiello has reported, most recent first.
InsiderAlpha's records for Dennis A. Ausiello go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Dennis A. Ausiello files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Dennis A. Ausiello is a corporate insider of Seres Therapeutics, Inc. (MCRB). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases and 11 open-market sales ($13.73M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$ALNY ALNYLAM PHARMACEUTICALS, INC.1.2K shares @ $441.88$532K